serum amyloid p component sap identical serum form amyloid p component ap kda pentameric protein first identified pentagonal constituent vivo pathological deposits called apcs human sap makes dry mass amyloid thought important contributor pathogenesis related group diseases called conditions characterised ordered aggregation normal globular proteins peptides insoluble fibres disrupt tissue architecture associated cell death sap thought decorate stabilise aggregates preventing proteolytic cleavage hence inhibiting fibril removal via normal protein scavenging association utilised routine clinical diagnostic technique sap scintigraphy whereby radiolabelled protein injected patients locate areas amyloid sapamyloid association also identified possible drug target antiamyloid therapy recent development first stage clinical trials compound called cphpc acid small molecule able strip ap deposits reducing levels circulating sap member pentraxins family characterised calciumdependent ligand binding distinctive flattened Î²jellyroll structure similar legume name pentraxin derived greek words five penta berries ragos relating radial symmetry five monomers forming ring approximately across deep human sap sequence homology creactive protein crp classical acute phase response plasma protein distant relative long pentraxins cytokinemodulated molecule several neuronal pentraxins sap crp evolutionary conserved vertebrates also found distant invertebrates horseshoe crab limulus serum amyloid p component cocrystallised mobdg neutral ph decameric damp complex human serum amyloid p component structure pentameric human serum amyloid p component decameric structure human serum amyloid pcomponent bound decameric crystal structure human serum amyloid pcomponent bound pentameric crystal structure human serum amyloid pcomponent bound httpsenwikipediaorgwikiserumamyloidpcomponent